Cardinal Health extends CVS Health distribution agreement
Compartilhar
Cardinal Health (NYSE:CAH) entered into a binding letter of intent with CVS Health to extend their existing pharmaceutical distribution agreement through June 30, 2032.
Cardinal Health (NYSE:CAH) entered into a binding letter of intent with CVS Health to extend their existing pharmaceutical distribution agreement through June 30, 2032.
Cardinal Health (NYSE:CAH) raised its fiscal year 2026 earnings outlook Tuesday, citing rapid acceleration in its specialty pharmaceutical business and a successful navigating of federal drug pricing changes.
Cardinal Health (NYSE:CAH) reported fiscal fourth-quarter 2026 revenue of $63.7 billion, up 6%, while GAAP operating earnings rose 70% to $729 million.
Cardinal Health (NYSE:CAH) delivered a blowout second quarter on Thursday, significantly raising its full-year outlook as the drug wholesaler cashes in on robust demand for specialty therapeutics and high-margin GLP-1 medications.
